Woojin Kim

Woojin Kim has extensive work experience in the field of scientific research. Woojin currently holds the position of Principal Scientist at Morphic Therapeutic, where they have been working since February 2023. Prior to this role, they served as a Senior Scientist at Morphic Therapeutic starting from February 2021. Before joining Morphic Therapeutic, Woojin Kim worked as a Research Scientist II at the same company from March 2019 to February 2021.

Woojin Kim has also held positions at various prestigious institutions, including Boston Children's Hospital / Harvard Medical School. Woojin was appointed as a Senior Staff Scientist at this institution from February 2017 to February 2019. Prior to that, Woojin Kim worked as an Instructor at Dana-Farber Cancer Institute / Harvard Medical School from November 2013 to January 2017.

Woojin Kim began their career as a Postdoctoral Research Fellow at Harvard Medical School / Boston Children's Hospital, where they worked from August 2007 to October 2013. Woojin also worked as a Research Fellow at Princeton University from January 2006 to May 2007. Additionally, they completed their Ph.D. at Princeton University from September 2001 to December 2006.

Woojin Kim holds a Doctor of Philosophy (Ph.D.) degree in Biochemistry from Princeton University, which was obtained from 2001 to 2006. Prior to that, from 1995 to 1998, they completed their Bachelor of Science (B.S.) in Chemistry at Seoul National University.